Bank of America appoints Baxter CEO José E. Almeida to board of directors

BANK OF AMERICA CORP /DE/

José E. Almeida, 59, chairman/president/CEO of Baxter International, appointed effective September 14, 2022.
Almeida will serve on the Audit Committee and Compensation and Human Capital Committee.
He previously led Covidien and held board roles at Walgreens Boots Alliance, Analog Devices, EMC, and State Street.
He receives prorated restricted stock and cash awards per the non-employee director compensation program.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

José E. Almeida

Director

BAC · BANK OF AMERICA CORP /DE/

Effective: 2022-09-14
Filed: September 14, 2022, 7:59 PM ET

On September 14, 2022, the board of directors (the “Board”) of Bank of America Corporation (the “Corporation”) appointed Mr. José (Joe) E. Almeida to serve on the Board effective immediately, and also appointed Mr. Almeida to serve on the Board’s Audit Committee and Compensation and Human Capital Committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

José E. Almeida was appointed as Director at BANK OF AMERICA CORP /DE/.

Action: appointed
Role: Director

Exact text from the filing

On September 14, 2022, the board of directors (the “Board”) of Bank of America Corporation (the “Corporation”) appointed Mr. José (Joe) E. Almeida to serve on the Board effective immediately, and also appointed Mr. Almeida to serve on the Board’s Audit Committee and Compensation and Human Capital Committee.

View on SEC.gov

BANK OF AMERICA CORP /DE/ filing history →

Source: SEC EDGAR

accession 0000070858-22-000119

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.